Clinical trials
Phase 2 Pleural Effusion trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| CanBas Co. Ltd. | 1 |
| Daryoush Hamidi Alamdari, PhD | 1 |
| Delta University for Science and Technology | 1 |
| Genzyme, a Sanofi Company | 1 |
| Hospital Infanta Sofia | 1 |
| Huazhong University of Science and Technology | 1 |
| McMaster University | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pleural Effusion | 15 |
| Lung Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Pleural Effusion, Malignant | 3 |
| Ascites | 2 |
| Empyema | 2 |
| Chylothorax | 1 |
| Chylous Ascites | 1 |
| Empyema, Pleural | 1 |
| Lymphangioleiomyomatosis | 1 |
Trials
Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.